- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00938249
Effects of Monascus Garlic Fermented Extract on Serum Triglyceride Level
April 23, 2010 updated by: Hiroshima University
Effects of Monascus Garlic Fermented Extract on Serum Triglyceride Level: a Double-Blind, Randomized Controlled Trial
The purpose of the study is to determine the effect of monascus garlic fermented extract on serum lipid concentrations in subjects with moderately elevated serum triglyceride.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hiroshima, Japan, 734-8551
- Hiroshima University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy as based on medical history and physical examination
- Fasting serum triglyceride 120 to 200mg/dl
- Willing not to serve as blood donor during the study
- Informed consent signed
Exclusion Criteria:
- Female subjects who are pregnant or nursing a child
- Participation in any clinical trial up to 90 days before Day 1 of this study
- Renal or hepatic dysfunction
- Heart disease
- Under medication
- Subjects who are taking functional food designed for weight loss or serum lipid reduction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
|
Experimental: Monascus Garlic Fermented Extract
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Fasting triglyceride level
Time Frame: Every 4 weeks (Overall 20 weeks)
|
Every 4 weeks (Overall 20 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Abdominal circumference
Time Frame: Every 4 weeks (Overall 20 weeks)
|
Every 4 weeks (Overall 20 weeks)
|
Visceral fat area by CT scan
Time Frame: Week 0 and Week 12
|
Week 0 and Week 12
|
Serum total cholesterol and LDL cholesterol levels
Time Frame: Every 4 weeks (Overall 20 weeks)
|
Every 4 weeks (Overall 20 weeks)
|
Serum adiponectin level
Time Frame: Week 0 and Week 12
|
Week 0 and Week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2009
Primary Completion (Actual)
February 1, 2010
Study Completion (Actual)
February 1, 2010
Study Registration Dates
First Submitted
July 10, 2009
First Submitted That Met QC Criteria
July 10, 2009
First Posted (Estimate)
July 13, 2009
Study Record Updates
Last Update Posted (Estimate)
April 26, 2010
Last Update Submitted That Met QC Criteria
April 23, 2010
Last Verified
April 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- eki-146
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States